Other
Father of bone marrow transplant is dead at 92
E. Donnall Thomas, a physician who pioneered bone marrow transplants and later won the 1990 Nobel Prize in medicine, has died in Seattle at age 92.
Oct 21, 2012
0
0
Page 37 - News tagged with bone cancer cells
Oncology & Cancer
DNA method can provide more effective treatment of childhood cancer
After leukaemia and brain tumours, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for ...
Oct 15, 2012
0
0
Oncology & Cancer
Discovery reveals important clues to cancer metastasis
In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, ...
Oct 11, 2012
0
0
Oncology & Cancer
New tool determines leukemia cells' 'readiness to die,' may guide clinical care
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more ...
Oct 11, 2012
0
0
Diabetes
New biological pathway discovery may help scientists redesign certain diabetes drugs to reduce adverse side effects
University of Iowa team discovers new biological pathway in blood vessel cells, which may contribute to the blood pressure-lowering effects of TZD drugs used to treat Type 2 diabetes. This finding may help to develop new ...
Oct 9, 2012
0
0
Immunology
Researchers harness the immune system to improve stem cell transplant outcomes
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant ...
Oct 1, 2012
0
0
Oncology & Cancer
Denosumab reduces burden of giant-cell tumor of the bone
Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according ...
Sep 21, 2012
0
0
Immunology
Researchers find novel predictor for MDS progression risk
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) ...
Sep 13, 2012
0
0
Oncology & Cancer
Race, ethnicity affect likelihood of finding suitable unrelated stem cell donor for cancer patients
(Medical Xpress)—Researchers at Moffitt Cancer Center and colleagues have published a study describing the greater difficulty in finding matched, unrelated donors for non-Caucasian patients who are candidates for hematopoietic ...
Sep 11, 2012
0
0
Oncology & Cancer
Improved diagnostic test benefits children with acute myeloid leukemia
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Sep 10, 2012
0
0
